Mascoma Wealth Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Hold	0	–	–	–	614
2023 Q1	–	Hold	0	–	–	–	681